The global synthetic biology market size was estimated at USD 16.2 billion in 2024 and is projected to reach USD 42.06 billion by 2030, growing at a CAGR of 17.30% 2025 to 2030. A primary factor driving this expansion is the emergence of novel applications for synthetic biology technologies. These include advanced areas such as multiplexed diagnostics, which allow simultaneous detection of multiple biological markers, cellular recording, which involves tracking cellular events and states over time, and therapeutic genome editing, where genetic material is precisely altered to treat diseases. The growing demand for synthetic biology products in these cutting-edge fields is expected to significantly contribute to market growth during the forecast period.

Moreover, the integration of synthetic biology-based products and methodologies into diverse sectors such as energy and chemicals is anticipated to further accelerate the overall market expansion. As synthetic biology applications continue to diversify and penetrate new industries, their utility and relevance increase, thereby encouraging wider adoption and propelling the market forward.

The impact of the COVID-19 pandemic has also played a crucial role in elevating the use and development of synthetic biology products over recent years. During the pandemic, numerous leading pharmaceutical and biotechnology companies, along with other key synthetic biology stakeholders, intensified their research activities globally. They utilized innovative synthetic biology techniques to develop critical healthcare solutions, including diagnostic test kits, therapeutic treatments, and vaccines targeting COVID-19. Supporting this trend, a study conducted by the European Parliament recognized synthetic biology as a rapidly advancing technology with promising applications for combating COVID-19 infections. Similarly, the U.S. National Institutes of Health (NIH) has highlighted synthetic biology as an essential tool to accelerate vaccine development efforts, underscoring the technology’s importance in addressing global health challenges.

Key Market Trends & Insights:

• In 2024, the North American synthetic biology market held the largest share globally, accounting for 41.98% of the total market revenue. This significant dominance highlights the region’s well-established infrastructure, advanced research capabilities, and substantial investments in biotechnology and synthetic biology sectors.

• Meanwhile, the Asia Pacific region is anticipated to experience the fastest growth, with a projected compound annual growth rate (CAGR) of 18.91% over the forecast period. This rapid expansion is driven by increasing government support, rising investments in biotechnology, and growing adoption of synthetic biology technologies in emerging economies within the region.

• Examining the market by product type, the enzymes segment emerged as the market leader in 2024, capturing a notable revenue share of 36.79%. Enzymes play a critical role in synthetic biology applications due to their ability to catalyze biochemical reactions, making them essential for various industrial, pharmaceutical, and research purposes.

• From a technological perspective, the polymerase chain reaction (PCR) segment accounted for the largest share, comprising 30.07% of the market in 2024. PCR technology is fundamental in synthetic biology as it enables the amplification and analysis of DNA sequences, facilitating genetic engineering, diagnostics, and research.

• When considering end-use industries, biotechnology and pharmaceutical companies dominated the market in 2024, capturing the largest revenue share of 54.92%. This dominance is attributed to their extensive use of synthetic biology techniques for drug discovery, development of therapeutics, and manufacturing of biopharmaceutical products, driving significant demand within this segment.

Order a free sample PDF of the Synthetic Biology Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 16.2 Billion

• 2030 Projected Market Size: USD 42.06 Billion

• CAGR (2025-2030): 17.30%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Companies operating within the synthetic biology industry are actively pursuing strategies centered around expansion to boost both their production capacities and research initiatives. In order to solidify their market position, many of these key players are engaging in acquisitions of smaller firms. This approach enables them to broaden their service portfolios, tap into new technologies, and enhance their overall operational capabilities. By integrating the expertise and resources of these acquired companies, industry participants aim to accelerate innovation, improve efficiency, and better meet the evolving demands of the synthetic biology market.

Key Players

• Bota Biosciences Inc.

• Codexis, Inc.

• Creative Biogene.

• Creative Enzymes.

• Enbiotix, Inc.

• Illumina, Inc.

• Merck Kgaa (Sigma-Aldrich Co. Llc)

• New England Biolabs

• Eurofins Scientific

• Novozymes

• Pareto Bio, Inc.

• Scarab Genomics, Llc

• Synthego

• Synthetic Genomics Inc.

• Thermo Fisher Scientific, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The synthetic biology market is poised for rapid growth driven by advancements in technologies such as genome editing, multiplexed diagnostics, and therapeutic applications. Increasing integration of synthetic biology across various industries, including pharmaceuticals, agriculture, and energy, is expanding its utility. Strong R&D investments, strategic acquisitions, and growing awareness about the benefits of synthetic biology are further propelling market expansion globally.